Clinical Management

  • Hospitalization is not required for mild presentations. Patients should be aware of potential progression of illness
  • Use conservative fluid management when there is no evidence of shock
  • Advanced organ support including hemodynamic support, mechanical ventilation, and renal replacement may be necessary


Corticosteroids are indicated in patients requiring mechanical ventilation or supplemental oxygen

Dexamethasone 6 mg PO/IV q24h for up to ten days

Other Treatments

  • Oseltamivir is not recommended for COVID-19, as there are no known clinical benefits
  • Oseltamivir is not currently recommended as seasonal influenza remains low
  • Investigational anti-COVID-19 therapeutics should be used only in approved, randomized, controlled trials
  • Randomized controlled trials are underway to identify potentially effective therapeutics